enzymelink
immunosorb
assay
elisa
develop
diagnos
human
coronaviru
hcv
infect
children
one
hundr
seventi
seven
nose
swab
throat
swab
nasopharyng
aspir
collect
children
suffer
acut
respiratori
infect
sampl
test
hcv
antigen
eltsa
sampl
shown
hcv
posit
result
indic
elisa
prove
use
diagnosi
hcv
infect
children
studi
progress
extend
elisa
detect
hcv
experiment
natur
acquir
infect
adult
human
coronavirus
hcv
caus
mild
upper
respiratori
tract
infect
common
cold
adult
children
cold
associ
hcv
larson
et
al
mcintosh
monto
howev
previou
studi
use
chang
serum
antibodi
confirm
hcv
infect
bradburn
tyrrel
mcintosh
monto
studi
report
isol
detect
hcv
nasal
secret
due
fastidi
growth
requir
hcv
isol
tissu
organ
cultur
hamr
procknow
larson
et
al
mcintosh
et
al
tyrrel
byno
nevertheless
one
studi
use
immunofluoresc
detect
hcv
antigen
epitheli
cell
shed
nasopharynx
volunt
inocul
hcv
mcintosh
et
al
howev
hcv
detect
method
similar
cell
shed
nasal
secret
children
natur
acquir
respiratori
infect
mcintosh
et
al
paper
describ
elisa
detect
hcv
hcv
antigen
group
hcv
hcv
group
mcnaughton
macnaughton
et
al
mcintosh
mcintosh
et
al
nose
swab
throat
swab
nasopharyng
aspir
taken
children
suffer
acut
respiratori
infect
thirti
children
age
month
year
recurr
upper
lower
respiratori
tract
infect
studi
octob
februari
detail
children
infect
describ
elsewher
isaac
et
al
isaac
et
al
sampl
compris
nose
swab
throat
swab
nasopharyng
aspir
collect
children
episod
respiratori
tract
infect
nose
throat
swab
taken
steril
wool
swab
broken
viral
transport
medium
contain
penicillin
streptomycin
amphotericin
neonat
mucou
extractor
mucou
trap
chilton
surgic
use
take
nasopharyng
aspir
ad
ml
viral
transport
medium
specimen
transport
laboratori
solid
carbon
dioxid
store
sampl
use
repres
sampl
collect
children
respiratori
tract
infect
includ
sampl
respiratori
virus
isol
well
sampl
virus
isol
deliber
select
specimen
test
although
specimen
respiratori
virus
isol
less
like
use
specimen
sometim
use
test
experi
approv
ethic
committe
northwick
park
hospit
harrow
england
repres
member
two
hcv
antigen
group
use
hcv
prototyp
viru
hcv
group
hamr
procknow
cv
pari
possibl
human
origin
isol
fece
neonat
necrot
enterocol
sureau
et
al
member
hcv
group
hcv
grown
mrc
continu
mrcc
cell
previous
describ
macnaughton
madg
cv
pari
grown
hrt
cell
rpmi
fetal
calf
serum
hasoni
macnaughton
virus
cell
frozen
thaw
result
suspens
clarifi
g
min
viru
prepar
pellet
g
hr
resuspend
ml
aliquot
dulbecco
phosphatebuff
salin
pbsa
resuspend
viru
sampl
overlaid
linear
ww
sucros
gradient
pbsa
centrifug
g
hr
viru
peak
gmml
collect
concentr
viru
particlesiml
sampl
determin
electron
microscopi
particl
count
macnaughton
et
al
immun
sera
hcv
cv
pari
prepar
adult
new
zealand
white
rabbit
kraaijeveld
et
al
amount
purifi
viru
concentr
viru
particlesml
determin
electron
microscopi
particl
count
macnaughton
et
al
mix
equal
volum
freund
complet
adjuv
inject
intracutan
differ
place
shaven
back
rabbit
two
day
immun
anim
receiv
ml
bordetella
pertussi
vaccin
lister
institut
prevent
medicin
elstre
england
intracutan
addit
adjuv
anim
bled
week
immun
sera
absorb
equal
volum
newborn
calf
serum
store
elisa
method
use
base
method
describ
previous
detect
antibodi
hcv
kraaijeveld
et
al
flatbottom
polystyren
microtit
plate
dynatech
coat
duplic
amount
antigen
dilut
carbonatebicarbon
buffer
ph
incub
overnight
room
temperatur
incub
plate
wash
four
time
phosphatebuff
salin
contain
tween
sodium
azid
pbst
shaken
dri
portion
ml
sera
dilut
pbst
ad
well
incub
hr
room
temperatur
incub
plate
wash
four
time
pbst
shaken
dri
antirabbit
immunoglobulin
g
direct
heavi
light
chain
label
alkalin
phosphatas
conjug
mile
laboratori
dilut
ad
quantiti
left
overnight
room
temperatur
four
addit
wash
pbst
ml
phosphatas
substrat
consist
solut
pnitrophenylphosph
wthol
diethanolamin
buffer
ph
sodium
azid
ad
well
absorb
valu
read
min
nm
flow
titertek
multiscan
photomet
figur
show
elisa
absorb
valu
obtain
number
hcv
concentr
pbsa
use
dilut
posit
hcv
rabbit
antiserum
neg
antiserum
rabbit
call
ratio
posit
neg
hcv
antisera
absorb
valu
serum
dilut
elisa
ratio
tabl
show
elisa
ratio
calcul
figur
elisa
ratio
semm
dilut
pbsa
respect
case
lower
antigen
concentr
test
produc
similar
elisa
ratio
obtain
pbsa
might
expect
elisa
ratio
approxim
ie
would
similar
nonspecif
bind
sera
elisa
plate
howev
increas
nonspecif
bind
posit
sera
plate
rel
neg
sera
presum
reflect
higher
immunoglobulin
content
posit
sera
suggest
lowest
hcv
concentr
reliabl
detect
elisa
ratio
least
twice
obtain
pbsa
ie
concentr
ellsa
ratio
serum
dilut
respect
tabl
show
particl
per
ml
could
detect
serum
dilut
x
particl
per
ml
could
detect
serum
dilut
chequerboard
titrat
show
serum
dilut
gener
satisfactori
detect
hcv
antigen
similar
studi
done
detect
cv
pari
elisa
use
posit
neg
cv
pari
antisera
produc
rabbit
chequerboard
titrat
show
x
particlesml
could
detect
use
serum
dilut
case
elisa
ratio
obtain
pbsa
suggest
sampl
posit
cv
pari
antigen
elisa
ratio
least
twice
valu
ie
criteria
detect
hcv
antigen
describ
use
analysi
sampl
taken
children
respiratori
infect
sampl
compris
mostli
nose
swab
also
includ
throat
swab
nasopharyng
aspir
chequerboard
titrat
sever
sampl
show
dilut
nasal
sampl
produc
highest
absorb
valu
dilut
rabbit
serum
sampl
dilut
therefor
use
follow
experi
figur
show
elisa
ratio
obtain
dilut
children
nasal
specimen
use
dilut
antisera
hcv
fig
cv
pari
fig
wide
rang
elisa
ratio
obtain
hcv
cv
pari
antisera
describ
elisa
ratio
hcv
antisera
cv
pari
antisera
consid
contain
hcv
cv
pari
antigen
respect
shown
previous
hcv
cv
pari
repres
member
hcv
hcv
antigen
group
hcv
detect
elisa
use
one
antigen
hasoni
macnaughton
kraaijeveld
et
al
macnaughton
macnaughton
et
al
thu
sampl
posit
hcv
group
virus
sampl
posit
hcv
group
virus
three
sampl
posit
hcv
antigen
group
sampl
posit
one
hcv
antigen
group
tabl
show
number
nose
throat
swab
nasopharyng
aspir
specimen
use
studi
percentag
detect
hcv
highest
detect
rate
hcv
nose
swab
hcv
detect
nose
swab
throat
swab
nasopharyng
aspir
first
studi
report
detect
hcv
antigen
elisa
nose
swab
throat
swab
nasopharyng
aspir
taken
children
natur
acquir
respiratori
infect
past
elisa
shown
one
sensit
method
detect
hcv
antibodi
rise
volunt
inocul
number
hcv
isol
kradijeveld
et
al
macnaughton
et
al
elisa
use
previous
adapt
detect
hcv
clinic
specimen
specimen
contain
least
hcv
particl
per
ml
detect
present
difficult
compar
detect
hcv
antigen
specimen
elisa
method
isol
hcv
isol
organ
andor
tissu
cultur
difficult
tediou
hamr
procknow
larson
et
al
mcintosh
et
al
tyrrel
byno
detect
hcv
sampl
higher
previous
observ
children
use
seroepidemiolog
method
kay
et
al
mcintosh
et
al
presum
reflect
high
sensit
elisa
method
howev
number
sampl
contain
hcv
probabl
underestim
criteria
use
decid
sampl
contain
hcv
antigen
rigor
sampl
contain
less
hcv
particl
per
rnl
would
detect
forti
six
sampl
posit
hcv
group
virus
seven
posit
hcv
group
virus
result
unexpect
incid
hcv
isol
popul
follow
complex
cyclic
pattern
sampl
studi
taken
period
month
infect
group
hcv
occur
yr
cycl
mcintosh
monto
interest
noseswab
specimen
contain
hcv
antigen
hcv
detect
throat
swab
nasopharyng
aspir
thu
appear
although
hcv
replic
throughout
upper
respiratori
tract
hcv
replic
probabl
occur
nasal
epitheli
cell
would
use
confirm
identif
hcv
antigen
nasal
secret
observ
hcv
antibodi
rise
children
sera
hcv
infect
howev
prove
difficult
obtain
appropri
preinfect
serum
sampl
hcv
infect
occur
frequent
popul
often
produc
subclin
infect
macnaughton
children
studi
recurr
upper
lower
respiratori
tract
infect
case
hcv
antigen
appear
persist
nasal
secret
period
sever
month
macnaughton
unpublish
result
conclus
develop
elisa
detect
hcv
isol
nose
swab
throat
swab
nasopharyng
aspir
children
respiratori
infect
nasal
swab
prove
use
specimen
detect
hcv
elisa
studi
progress
extend
elisa
detect
hcv
antigen
nasal
wash
nose
swab
volunt
inocul
hcv
adult
natur
acquir
hcv
infect
